Industry Research Reports

Home > Reports > Pharma & Healthcare > Oral Proteins and Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Oral Proteins and Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published: 2025-01-02

Pages: 84 Pages

Report ld: 3427356

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Oral Proteins and Peptides was estimated to be worth US$ 2968 million in 2024 and is forecast to a readjusted size of US$ 7824 million by 2031 with a CAGR of 15.1% during the forecast period 2025-2031.

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

Ironwood & Allergan is one of the most important global  manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

This report aims to provide a comprehensive presentation of the global market for Oral Proteins and Peptides, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Proteins and Peptides by region & country, by Type, and by Application.

The Oral Proteins and Peptides market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Proteins and Peptides.

Market Segmentation

Report Metric
Details
Report Title
Oral Proteins and Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global Oral Proteins and Peptides Companies Covered
Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis, Chiasma (Amryt Pharma)
Global Oral Proteins and Peptides Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Proteins and Peptides Market, Segment by Type
Linaclotide

Insulin

Plecanatide

Cyclosporine

Octreotide
Global Oral Proteins and Peptides Market, Segment by Application
Gastric & Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oral Proteins and Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oral Proteins and Peptides in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Oral Proteins and Peptides Product Introduction
    1.2 Global Oral Proteins and Peptides Market Size Forecast
        1.2.1 Global Oral Proteins and Peptides Sales Value (2020-2031)
        1.2.2 Global Oral Proteins and Peptides Sales Volume (2020-2031)
        1.2.3 Global Oral Proteins and Peptides Sales Price (2020-2031)
    1.3 Oral Proteins and Peptides Market Trends & Drivers
        1.3.1 Oral Proteins and Peptides Industry Trends
        1.3.2 Oral Proteins and Peptides Market Drivers & Opportunity
        1.3.3 Oral Proteins and Peptides Market Challenges
        1.3.4 Oral Proteins and Peptides Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Oral Proteins and Peptides Players Revenue Ranking (2024)
    2.2 Global Oral Proteins and Peptides Revenue by Company (2020-2025)
    2.3 Global Oral Proteins and Peptides Players Sales Volume Ranking (2024)
    2.4 Global Oral Proteins and Peptides Sales Volume by Company Players (2020-2025)
    2.5 Global Oral Proteins and Peptides Average Price by Company (2020-2025)
    2.6 Key Manufacturers Oral Proteins and Peptides Manufacturing Base and Headquarters
    2.7 Key Manufacturers Oral Proteins and Peptides Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Oral Proteins and Peptides
    2.9 Oral Proteins and Peptides Market Competitive Analysis
        2.9.1 Oral Proteins and Peptides Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Oral Proteins and Peptides Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Proteins and Peptides as of 2024)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Linaclotide
        3.1.2 Insulin
        3.1.3 Plecanatide
        3.1.4 Cyclosporine
        3.1.5 Octreotide
    3.2 Global Oral Proteins and Peptides Sales Value by Type
        3.2.1 Global Oral Proteins and Peptides Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Oral Proteins and Peptides Sales Value, by Type (2020-2031)
        3.2.3 Global Oral Proteins and Peptides Sales Value, by Type (%) (2020-2031)
    3.3 Global Oral Proteins and Peptides Sales Volume by Type
        3.3.1 Global Oral Proteins and Peptides Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Oral Proteins and Peptides Sales Volume, by Type (2020-2031)
        3.3.3 Global Oral Proteins and Peptides Sales Volume, by Type (%) (2020-2031)
    3.4 Global Oral Proteins and Peptides Average Price by Type (2020-2031)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Gastric & Digestive Disorders
        4.1.2 Bone Diseases
        4.1.3 Diabetes
        4.1.4 Hormonal Disorders
    4.2 Global Oral Proteins and Peptides Sales Value by Application
        4.2.1 Global Oral Proteins and Peptides Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Oral Proteins and Peptides Sales Value, by Application (2020-2031)
        4.2.3 Global Oral Proteins and Peptides Sales Value, by Application (%) (2020-2031)
    4.3 Global Oral Proteins and Peptides Sales Volume by Application
        4.3.1 Global Oral Proteins and Peptides Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Oral Proteins and Peptides Sales Volume, by Application (2020-2031)
        4.3.3 Global Oral Proteins and Peptides Sales Volume, by Application (%) (2020-2031)
    4.4 Global Oral Proteins and Peptides Average Price by Application (2020-2031)

 5 Segmentation by Region
    5.1 Global Oral Proteins and Peptides Sales Value by Region
        5.1.1 Global Oral Proteins and Peptides Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Oral Proteins and Peptides Sales Value by Region (2020-2025)
        5.1.3 Global Oral Proteins and Peptides Sales Value by Region (2026-2031)
        5.1.4 Global Oral Proteins and Peptides Sales Value by Region (%), (2020-2031)
    5.2 Global Oral Proteins and Peptides Sales Volume by Region
        5.2.1 Global Oral Proteins and Peptides Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Oral Proteins and Peptides Sales Volume by Region (2020-2025)
        5.2.3 Global Oral Proteins and Peptides Sales Volume by Region (2026-2031)
        5.2.4 Global Oral Proteins and Peptides Sales Volume by Region (%), (2020-2031)
    5.3 Global Oral Proteins and Peptides Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Oral Proteins and Peptides Sales Value, 2020-2031
        5.4.2 North America Oral Proteins and Peptides Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Oral Proteins and Peptides Sales Value, 2020-2031
        5.5.2 Europe Oral Proteins and Peptides Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Oral Proteins and Peptides Sales Value, 2020-2031
        5.6.2 Asia Pacific Oral Proteins and Peptides Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Oral Proteins and Peptides Sales Value, 2020-2031
        5.7.2 South America Oral Proteins and Peptides Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Oral Proteins and Peptides Sales Value, 2020-2031
        5.8.2 Middle East & Africa Oral Proteins and Peptides Sales Value by Country (%), 2024 VS 2031

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Oral Proteins and Peptides Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Oral Proteins and Peptides Sales Value
        6.2.1 Key Countries/Regions Oral Proteins and Peptides Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Oral Proteins and Peptides Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Oral Proteins and Peptides Sales Value, 2020-2031
        6.3.2 United States Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Oral Proteins and Peptides Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Oral Proteins and Peptides Sales Value, 2020-2031
        6.4.2 Europe Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Oral Proteins and Peptides Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Oral Proteins and Peptides Sales Value, 2020-2031
        6.5.2 China Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Oral Proteins and Peptides Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Oral Proteins and Peptides Sales Value, 2020-2031
        6.6.2 Japan Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Oral Proteins and Peptides Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Oral Proteins and Peptides Sales Value, 2020-2031
        6.7.2 South Korea Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Oral Proteins and Peptides Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Oral Proteins and Peptides Sales Value, 2020-2031
        6.8.2 Southeast Asia Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Oral Proteins and Peptides Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Oral Proteins and Peptides Sales Value, 2020-2031
        6.9.2 India Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Oral Proteins and Peptides Sales Value by Application, 2024 VS 2031

 7 Company Profiles
    7.1 Ironwood & Allergan
        7.1.1 Ironwood & Allergan Company Information
        7.1.2 Ironwood & Allergan Introduction and Business Overview
        7.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Ironwood & Allergan Oral Proteins and Peptides Product Offerings
        7.1.5 Ironwood & Allergan Recent Development
    7.2 Novo Nordisk
        7.2.1 Novo Nordisk Company Information
        7.2.2 Novo Nordisk Introduction and Business Overview
        7.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Novo Nordisk Oral Proteins and Peptides Product Offerings
        7.2.5 Novo Nordisk Recent Development
    7.3 Synergy Pharmaceuticals （Salix）
        7.3.1 Synergy Pharmaceuticals （Salix） Company Information
        7.3.2 Synergy Pharmaceuticals （Salix） Introduction and Business Overview
        7.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Offerings
        7.3.5 Synergy Pharmaceuticals （Salix） Recent Development
    7.4 Novartis
        7.4.1 Novartis Company Information
        7.4.2 Novartis Introduction and Business Overview
        7.4.3 Novartis Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Novartis Oral Proteins and Peptides Product Offerings
        7.4.5 Novartis Recent Development
    7.5 Chiasma (Amryt Pharma)
        7.5.1 Chiasma (Amryt Pharma) Company Information
        7.5.2 Chiasma (Amryt Pharma) Introduction and Business Overview
        7.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Offerings
        7.5.5 Chiasma (Amryt Pharma) Recent Development

 8 Industry Chain Analysis
    8.1 Oral Proteins and Peptides Industrial Chain
    8.2 Oral Proteins and Peptides Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Oral Proteins and Peptides Sales Model
        8.5.2 Sales Channel
        8.5.3 Oral Proteins and Peptides Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Oral Proteins and Peptides Market Trends
 Table 2. Oral Proteins and Peptides Market Drivers & Opportunity
 Table 3. Oral Proteins and Peptides Market Challenges
 Table 4. Oral Proteins and Peptides Market Restraints
 Table 5. Global Oral Proteins and Peptides Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Oral Proteins and Peptides Revenue Market Share by Company (2020-2025)
 Table 7. Global Oral Proteins and Peptides Sales Volume by Company (2020-2025) & (Kg)
 Table 8. Global Oral Proteins and Peptides Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Oral Proteins and Peptides Price by Company (2020-2025) & (US$/Mg)
 Table 10. Key Manufacturers Oral Proteins and Peptides Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Oral Proteins and Peptides Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Oral Proteins and Peptides
 Table 13. Global Oral Proteins and Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Proteins and Peptides as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Proteins and Peptides Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Oral Proteins and Peptides Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Oral Proteins and Peptides Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Oral Proteins and Peptides Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Oral Proteins and Peptides Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Oral Proteins and Peptides Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
 Table 22. Global Oral Proteins and Peptides Sales Volume by Type (2020-2025) & (Kg)
 Table 23. Global Oral Proteins and Peptides Sales Volume by Type (2026-2031) & (Kg)
 Table 24. Global Oral Proteins and Peptides Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Oral Proteins and Peptides Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Oral Proteins and Peptides Price by Type (2020-2025) & (US$/Mg)
 Table 27. Global Oral Proteins and Peptides Price by Type (2026-2031) & (US$/Mg)
 Table 28. Global Oral Proteins and Peptides Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Oral Proteins and Peptides Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Oral Proteins and Peptides Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Oral Proteins and Peptides Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Oral Proteins and Peptides Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Oral Proteins and Peptides Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
 Table 34. Global Oral Proteins and Peptides Sales Volume by Application (2020-2025) & (Kg)
 Table 35. Global Oral Proteins and Peptides Sales Volume by Application (2026-2031) & (Kg)
 Table 36. Global Oral Proteins and Peptides Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Oral Proteins and Peptides Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Oral Proteins and Peptides Price by Application (2020-2025) & (US$/Mg)
 Table 39. Global Oral Proteins and Peptides Price by Application (2026-2031) & (US$/Mg)
 Table 40. Global Oral Proteins and Peptides Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Oral Proteins and Peptides Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Oral Proteins and Peptides Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Oral Proteins and Peptides Sales Value by Region (2020-2025) & (%)
 Table 44. Global Oral Proteins and Peptides Sales Value by Region (2026-2031) & (%)
 Table 45. Global Oral Proteins and Peptides Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
 Table 46. Global Oral Proteins and Peptides Sales Volume by Region (2020-2025) & (Kg)
 Table 47. Global Oral Proteins and Peptides Sales Volume by Region (2026-2031) & (Kg)
 Table 48. Global Oral Proteins and Peptides Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Oral Proteins and Peptides Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Oral Proteins and Peptides Average Price by Region (2020-2025) & (US$/Mg)
 Table 51. Global Oral Proteins and Peptides Average Price by Region (2026-2031) & (US$/Mg)
 Table 52. Key Countries/Regions Oral Proteins and Peptides Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Oral Proteins and Peptides Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Oral Proteins and Peptides Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Oral Proteins and Peptides Sales Volume, (2020-2025) & (Kg)
 Table 56. Key Countries/Regions Oral Proteins and Peptides Sales Volume, (2026-2031) & (Kg)
 Table 57. Ironwood & Allergan Company Information
 Table 58. Ironwood & Allergan Introduction and Business Overview
 Table 59. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 60. Ironwood & Allergan Oral Proteins and Peptides Product Offerings
 Table 61. Ironwood & Allergan Recent Development
 Table 62. Novo Nordisk Company Information
 Table 63. Novo Nordisk Introduction and Business Overview
 Table 64. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 65. Novo Nordisk Oral Proteins and Peptides Product Offerings
 Table 66. Novo Nordisk Recent Development
 Table 67. Synergy Pharmaceuticals （Salix） Company Information
 Table 68. Synergy Pharmaceuticals （Salix） Introduction and Business Overview
 Table 69. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 70. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Offerings
 Table 71. Synergy Pharmaceuticals （Salix） Recent Development
 Table 72. Novartis Company Information
 Table 73. Novartis Introduction and Business Overview
 Table 74. Novartis Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 75. Novartis Oral Proteins and Peptides Product Offerings
 Table 76. Novartis Recent Development
 Table 77. Chiasma (Amryt Pharma) Company Information
 Table 78. Chiasma (Amryt Pharma) Introduction and Business Overview
 Table 79. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 80. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Offerings
 Table 81. Chiasma (Amryt Pharma) Recent Development
 Table 82. Key Raw Materials Lists
 Table 83. Raw Materials Key Suppliers Lists
 Table 84. Oral Proteins and Peptides Downstream Customers
 Table 85. Oral Proteins and Peptides Distributors List
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources


List of Figures
 Figure 1. Oral Proteins and Peptides Product Picture
 Figure 2. Global Oral Proteins and Peptides Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Oral Proteins and Peptides Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Oral Proteins and Peptides Sales Volume (2020-2031) & (Kg)
 Figure 5. Global Oral Proteins and Peptides Sales Price (2020-2031) & (US$/Mg)
 Figure 6. Oral Proteins and Peptides Report Years Considered
 Figure 7. Global Oral Proteins and Peptides Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Oral Proteins and Peptides Players Sales Volume Ranking (2024) & (Kg)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Proteins and Peptides Revenue in 2024
 Figure 10. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Linaclotide Picture
 Figure 12. Insulin Picture
 Figure 13. Plecanatide Picture
 Figure 14. Cyclosporine Picture
 Figure 15. Octreotide Picture
 Figure 16. Global Oral Proteins and Peptides Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Oral Proteins and Peptides Sales Value Market Share by Type, 2024 & 2031
 Figure 18. Global Oral Proteins and Peptides Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
 Figure 19. Global Oral Proteins and Peptides Sales Volume Market Share by Type, 2024 & 2031
 Figure 20. Global Oral Proteins and Peptides Price by Type (2020-2031) & (US$/Mg)
 Figure 21. Product Picture of Gastric & Digestive Disorders
 Figure 22. Product Picture of Bone Diseases
 Figure 23. Product Picture of Diabetes
 Figure 24. Product Picture of Hormonal Disorders
 Figure 25. Global Oral Proteins and Peptides Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 26. Global Oral Proteins and Peptides Sales Value Market Share by Application, 2024 & 2031
 Figure 27. Global Oral Proteins and Peptides Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
 Figure 28. Global Oral Proteins and Peptides Sales Volume Market Share by Application, 2024 & 2031
 Figure 29. Global Oral Proteins and Peptides Price by Application (2020-2031) & (US$/Mg)
 Figure 30. North America Oral Proteins and Peptides Sales Value (2020-2031) & (US$ Million)
 Figure 31. North America Oral Proteins and Peptides Sales Value by Country (%), 2024 VS 2031
 Figure 32. Europe Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Europe Oral Proteins and Peptides Sales Value by Country (%), 2024 VS 2031
 Figure 34. Asia Pacific Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Oral Proteins and Peptides Sales Value by Region (%), 2024 VS 2031
 Figure 36. South America Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 37. South America Oral Proteins and Peptides Sales Value by Country (%), 2024 VS 2031
 Figure 38. Middle East & Africa Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 39. Middle East & Africa Oral Proteins and Peptides Sales Value by Country (%), 2024 VS 2031
 Figure 40. Key Countries/Regions Oral Proteins and Peptides Sales Value (%), (2020-2031)
 Figure 41. Key Countries/Regions Oral Proteins and Peptides Sales Volume (%), (2020-2031)
 Figure 42. United States Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 43. United States Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
 Figure 44. United States Oral Proteins and Peptides Sales Value by Application (%), 2024 VS 2031
 Figure 45. Europe Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 46. Europe Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
 Figure 47. Europe Oral Proteins and Peptides Sales Value by Application (%), 2024 VS 2031
 Figure 48. China Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 49. China Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
 Figure 50. China Oral Proteins and Peptides Sales Value by Application (%), 2024 VS 2031
 Figure 51. Japan Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 52. Japan Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
 Figure 53. Japan Oral Proteins and Peptides Sales Value by Application (%), 2024 VS 2031
 Figure 54. South Korea Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 55. South Korea Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
 Figure 56. South Korea Oral Proteins and Peptides Sales Value by Application (%), 2024 VS 2031
 Figure 57. Southeast Asia Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 58. Southeast Asia Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
 Figure 59. Southeast Asia Oral Proteins and Peptides Sales Value by Application (%), 2024 VS 2031
 Figure 60. India Oral Proteins and Peptides Sales Value, (2020-2031) & (US$ Million)
 Figure 61. India Oral Proteins and Peptides Sales Value by Type (%), 2024 VS 2031
 Figure 62. India Oral Proteins and Peptides Sales Value by Application (%), 2024 VS 2031
 Figure 63. Oral Proteins and Peptides Industrial Chain
 Figure 64. Oral Proteins and Peptides Manufacturing Cost Structure
 Figure 65. Channels of Distribution (Direct Sales, and Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed

Description

The global market for Oral Proteins and Peptides was estimated to be worth US$ 2968 million in 2024 and is forecast to a readjusted size of US$ 7824 million by 2031 with a CAGR of 15.1% during the forecast period 2025-2031.

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

Ironwood & Allergan is one of the most important global  manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

This report aims to provide a comprehensive presentation of the global market for Oral Proteins and Peptides, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Proteins and Peptides by region & country, by Type, and by Application.

The Oral Proteins and Peptides market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Proteins and Peptides.

Market Segmentation